Sign In
Buy GLPG
$27.38
+0.0650 (+0.238%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex
Another Possible Source Of Alpha
11:37pm, Friday, 14'th Feb 2020
Last month, I showed the performance of a new version of my system's security selection method. Here, I update the performance of that security selection method
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
02:18pm, Wednesday, 12'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN )
Ziopharm Secondary, And Other News: The Good, Bad And Ugly Of Biopharma
11:10pm, Monday, 10'th Feb 2020
Ziopharm announced a dilutive secondary share offering. Gilead's earnings call and new strategy. Celsion has new safety data.
Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat
02:21pm, Wednesday, 05'th Feb 2020
Gilead's (GILD) earnings fall short of estimates but sales beat the same in the fourth quarter of 2019.
Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat
02:21pm, Wednesday, 05'th Feb 2020
Gilead's (GILD) earnings fall short of estimates but sales beat the same in the fourth quarter of 2019.
Vertex (VRTX) Hits 52-Week High, Can the Run Continue?
02:15pm, Wednesday, 05'th Feb 2020
Vertex (VRTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Vertex (VRTX) Hits 52-Week High, Can the Run Continue?
02:15pm, Wednesday, 05'th Feb 2020
Vertex (VRTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
12:43pm, Wednesday, 05'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Better Returns By Reducing Outliers
10:55pm, Tuesday, 28'th Jan 2020
Last November, I implemented a change in my system's security selection method, one which gave preference to less risky names based on data that they tended to
The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings
01:25pm, Wednesday, 22'nd Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceu
Martin Luther King Day Stock Reports
10:55pm, Monday, 20'th Jan 2020
A very strong currency today was the Japanese yen, a reaction to the slow-down in China's growth to barely over 6% and the mounting worries about the latest coronavirus from Wuhan.
7 Blockbuster Drugs Expected To Be Launched In 2020
07:18pm, Monday, 20'th Jan 2020
Biotech stocks had a fairly decent run in 2019, thanks to record deal flow , several path-breaking innovation in drug research & development and the positive broader market sentiment. New molecular en
